Company profile · Zofingen, Switzerland

Siegfried

CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply · Global CDMO manufacturing

Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.

Lead
Marcel Imwinkelried (verified ↗)
Address
Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland (source ↗)
Compliance
GMP manufacturing network
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global CDMO manufacturing
Capabilities
API Manufacturing · Finished-Dose Production · CDMO Supply Operations
Founded
1873
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Marcel Imwinkelried

Chief Executive Officer

Check official leadership source
Full addressUntere Brühlstrasse 4, CH-4800 Zofingen, Switzerland
Site coordinates47.288356, 7.939630
Review cycleMay 2026
Physical site source

Official Siegfried Zofingen location page listing Untere Brühlstrasse 4, Zofingen.

Open source
Operating profile

Global CDMO manufacturing

Zofingen, Switzerland. CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply. Review completed on 14 Mar 2026.

2026 technical specializationCDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
Core capabilities
API ManufacturingFinished-Dose ProductionCDMO Supply Operations
Governance

Swiss, EU, and global pharmaceutical manufacturing oversight

GMP manufacturing network, Multi-site pharmaceutical quality systems

Editorial note

CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply

Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.

Related companies
Editorial note

Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

API Manufacturing
Finished-Dose Production
CDMO Supply Operations
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceSiegfried official leadership page confirming Marcel Imwinkelried as CEO from 1 January 2026.Source origin: siegfried.chOpen source
Supporting evidenceSiegfried official company surface outlining the production network.Source origin: siegfried.chOpen source
Physical-site evidenceOfficial Siegfried Zofingen location page listing Untere Brühlstrasse 4, Zofingen.Source origin: siegfried.chOpen source
Infrastructure

Declared infrastructure

API production suites
Finished-dose lines
Analytical quality laboratories
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Siegfried located?
Siegfried operates from Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland, Zofingen, Switzerland.
Who runs Siegfried?
Siegfried is led by Marcel Imwinkelried, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Siegfried hold?
Siegfried is documented under GMP manufacturing network.
What does Siegfried do?
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile. Core capabilities: API Manufacturing, Finished-Dose Production, CDMO Supply Operations.
Editorial context

Related technical briefs

Briefs that name Zofingen as a covered market or city.